Dr. Reddy's Laboratories Limited gets Form 483 from USFDA with 4 observations for API facility

The United States Food & Drug Administration (USFDA) today completed a GMP inspection at Dr. Reddy's Laboratories Limited's API manufacturing facility (CTO-6) in Srikakulam, Andhra Pradesh. The inspection was conducted from May 30, 2024 to June 7, 2024. The company has been issued a Form 483 with four observations, which we will address within the stipulated timeline.

Shares of Dr. Reddy's Laboratories Limited was last trading in BSE at Rs. 6059.05 as compared to the previous close of Rs. 5897.05. The total number of shares traded during the day was 23484 in over 4921 trades.

The stock hit an intraday high of Rs. 6083.80 and intraday low of 5879.75. The net turnover during the day was Rs. 141393597.00.

Source : Equity Bulls

Keywords

DrReddysLaboratories INE089A01023 RDY GMPInspection APIFacility Srikakulam Form483 4Observations